# US 2021/0330740 A1 · Runx3 modified protein for prevention or treatment of cancer

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0330740 A1
- Document ID: US20210330740A1
- Status: Published application
- Kind: A1
- Application number: 17/239,289
- Filed: 2021-04-23
- Published: 2021-10-28
- Earliest claimed: 2020-04-23
- Assignees: Run-x Corporation
- Applicants: Run-x Corporation
- Inventors: Suk Chul Bae; Jung Won Lee; You Soub Lee
- Web page: https://patentgrep.com/patent/US20210330740A1

## CPC

- A61K 38/17: from animals; from humans {(enzyme inhibitors A61K38/005)}
- A61K 31/436: the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
- A61K 31/519: ortho- or peri-condensed with heterocyclic rings
- A61K 38/1709: {from mammals}
- A61K 47/46: Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
- A61P 35/00: Antineoplastic agents
- C07K 14/4702: {Regulators; Modulating activity}
- C12N 7/00: Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00)
- C12N 2710/10343: viral genome or elements thereof as genetic vector
- C12N 2750/14143: viral genome or elements thereof as genetic vector
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

In the present invention, it was confirmed that the modified protein in which the 356th serine of Runx3 is substituted with alanine has an increased activity of maintaining the complex with Brd2 by more than 10 times compared to the wild-type Runx3, and the apoptosis effect is improved in various cancer cell lines compared to the wild-type Runx3. Therefore, the modified protein in which the 356th serine of Runx3 is substituted with an amino acid that cannot be phosphorylated by a kinase of the present invention, the polynucleotide coding thereof, the vector carrying the polynucleotide, or the virus or cell transformed with the vector can be used as a therapeutic agent for various cancers.

## Claims

### Claim 1

A method for treating cancer comprising a modified protein in which the 356th serine of Runx3 (Runt-related transcription factor 3) protein is substituted with an amino acid that cannot be phosphorylated by a kinase, a polynucleotide encoding thereof, a vector carrying the polynucleotide, or a virus or cell transformed with the vector in a pharmaceutically effective amount to a subject in need thereof.

### Claim 2 (depends on 1)

The method for treating cancer according to claim 1, wherein the cancer is solid cancer.

### Claim 3 (depends on 2)

The method for treating cancer according to claim 2, wherein the solid cancer is one or more selected from the group consisting of lung cancer, pancreatic cancer, liver cancer and stomach cancer.

### Claim 4 (depends on 1)

The method for treating cancer according to claim 1, wherein the amino acid that cannot be phosphorylated by a kinase is one or more selected from the group consisting of alanine (A), isoleucine (I), leucine (L) and valine (V).

### Claim 5 (depends on 1)

The method for treating cancer according to claim 1, wherein the Runx3 protein is composed of the amino acid sequence represented by SEQ. ID. NO: 1 or SEQ. ID. NO: 2.

### Claim 6 (depends on 1)

The method for treating cancer according to claim 1, wherein the polynucleotide coding the Runx3 modified protein is composed of the nucleotide sequence represented by SEQ. ID. NO: 3 or SEQ. ID. NO: 4.

### Claim 7 (depends on 1)

The method for treating cancer according to claim 1, wherein the vector is linear DNA or plasmid DNA.

### Claim 8 (depends on 1)

The method for treating cancer according to claim 1, wherein the virus is any one selected from the group consisting of retrovirus, adenovirus, herpes simplex virus and lentivirus.

### Claim 9 (depends on 1)

The method for treating cancer according to claim 1, wherein the cell is bacterium.

### Claim 10 (depends on 9)

The method for treating cancer according to claim 9, wherein the bacterium is Listeria, Shigella, Salmonella, or E. coli.
